Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes
- 19 June 2007
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 37 (8), 623-628
- https://doi.org/10.1111/j.1365-2362.2007.01834.x
Abstract
Background Evidence suggests that soluble CD40-ligand (sCD40L) is elevated in coronary artery disease (CAD) and is released from activated platelets during the acute myocardial infarction (AMI). Although sCD40L is part of immune response, the mechanisms regulating its release in different disease states remain unknown. Materials and methods This study enrolled 596 subjects: 201 patients with stable CAD, 109 patients with AMI and 286 healthy controls. Circulating levels of sCD40L, interleukin-6 (IL-6), soluble vascular cell adhesion molecule-a (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) were determined by enzyme-linked immunosorbent assay (ELISA). Results Patients with AMI (n = 109) had higher levels of sCD40L and IL-6 compared to both CAD (n = 201) (P < 0·01) and controls (n = 286) (P < 0·01), while CAD also had higher levels of sCD40L and IL-6 compared to controls (P < 0·01). Similarly, sICAM-1 and sVCAM-1 levels were higher in CAD and AMI compared to controls (P < 0·05). IL-6 was the only parameter independently associated with sCD40L in healthy individuals [β (SE):0·491(0·096), P = 0·0001]. However, in CAD or AMI, only diabetes mellitus [β (SE): 2·689 (1·082), P = 0·044 and β (SE): 10·406 (3·215), P = 0·002, respectively] and smoking [β (SE): 3·470 (1·111), P = 0·002 and β (SE): 9·694 (2·478), P = 0·0001, respectively] (but not IL-6), were independently associated with sCD40L levels. Conclusions Both CAD and AMI are accompanied by increased levels of sCD40L in parallel with an elevation of proinflammatory cytokine IL-6 and adhesion molecules sVCAM-1 and sICAM-1. Diabetes mellitus and smoking (but not IL-6 or adhesion molecules) were the only factors independently associated with sCD40L levels in CAD and AMI patients.Keywords
This publication has 41 references indexed in Scilit:
- Genetic Polymorphisms of Platelet Glycoprotein Ia and the Risk for Premature Myocardial InfarctionJournal of the American College of Cardiology, 2006
- Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarctionInternational Journal of Cardiology, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Activation of the complement system: a crucial link between inflammation and atherosclerosis?European Journal of Clinical Investigation, 2004
- Early Effect of Pravastatin on Serum Soluble CD40L, Matrix Metalloproteinase-9, and C-Reactive Protein in Patients with Acute Myocardial InfarctionClinical Chemistry, 2004
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic PatientsCirculation, 2003
- Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Lymphocyte Activation in Angina PectorisClinical Immunology, 1999